Women and Heart Disease Series: Diagnosis and Management of Chemotherapy-Induced Cardiotoxicity in Breast Cancer Survivors

Women and Heart Disease Series: Diagnosis and Management of Chemotherapy-Induced Cardiotoxicity in Breast Cancer Survivors is organized by American College of Cardiology (ACC).

Date of Release: Sep 11, 2019
Term of Approval/Date of CME/CE Expiration: Sep 11, 2020

Target Audience:
This activity is intended for cardiovascular adult physicians, internists, family physicians, and physician assistants.

Credit Offered:
• 0.25 CME Credit
• 0.25 MOC Credit

Description:
This activity was planned with a goal to change your competence in treating patients with cardiotoxicity from breast cancer therapies.

Learning Objectives:
Upon completion of this program, you should be able to:
• Recognize the diagnostic tools available for detection of cancer therapy-related cardiotoxicity and develop an approach to utilize them.
• Recognize the current approaches for both preventing and managing cancer therapy-related cardiac dysfunction.

Additional details will be posted as soon as information is available.